A.M. Bolibok

A.M. Bolibok

Auto-generated profile, based on publicly available information

A.M. Bolibok


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2021 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
DODmitry Ovsyannikov
Dmitry Ovsyannikov
MHMoscow Morozov Children’s City Clinical Hospital
Moscow Morozov Children’s City Clinical Hospital
TETatyana Eliseeva
Tatyana Eliseeva
MKM. Khaled
M. Khaled
OAO.V. Alekseeva
O.V. Alekseeva
EBE.Yu. Bryksina
E.Yu. Bryksina
The review, based on modern literature data and the results of many years of research conducted by the authors, highlights the problem of comorbidity (multimorbidity) in children with bronchial asthma (BA). There is a grouping of concomitant diseases in children with asthma depending on the type of comorbidity (causal, complicated, unspecified, reverse). Based on epidemiological data, observational and cohort studies, systematic reviews and meta-analyses, information on the frequency of BA in children with various comorbid diseases and comorbid diseases in children with BA was summarized. Scientific, theoretical and practical significance of comorbidity in BA, diagnostic and treatment programs in pediatric patients suffering from BA and comorbid diseases are substantiated.

13 April 2020 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
IKI.V. Krsheminskaya
I.V. Krsheminskaya
DKD.A. Kravchuk
D.A. Kravchuk
DODmitry Ovsyannikov
Dmitry Ovsyannikov
ABA.M. Bolibok
A.M. Bolibok
EPE.S. Pavlova
E.S. Pavlova
VLV.N. Larina
V.N. Larina
Облако Mail.ru - это ваше персональное надежное хранилище в интернете.

17 February 2023 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
MKM.A. Karpenko
M.A. Karpenko
DODmitry Ovsyannikov
Dmitry Ovsyannikov
ESE.V. Shchepkina
E.V. Shchepkina
M(Moscow Russian Presidential Academy Of National Economy And Public Administration (Ranepa)
Moscow Russian Presidential Academy Of National Economy And Public Administration (Ranepa)
OBO.V. Bystrova
O.V. Bystrova
VLV.N. Larina
V.N. Larina
Neuroendocrine cell hyperplasia of infancy (NEHI) is a rare interstitial lung disease in children. The clinical features of the disease are characterized by tachypnea, moist rales/crepitus, retraction of compliant chest areas and delayed weight gain. The disease is diagnosed using the NEHI clinical scale coupled with the computed tomography of the chest organs. The clinical manifestations of NEHI regress as the child grows, but may persist up to the age of 10 y/o. The purpose of the research was to characterize the course of NEHI including the features of COVID-19 and the impact of passive smoking in children below the age of 8 y/o. Materials and methods: a single-center longitudinal study with follow-up observation of 29 patients with NEHI in January 2012 - December 2022 aged 8 months to 8 years old, 21 of which had COVID-19. Results: 20 of 29 patients with a known follow-up have undergone the long-term oxygen therapy (LTOT) at home lasting from 2 weeks up to 5.5 years (Me 1 year and 2 months; IQR 6 months - 4.5 years). Bronchial asthma was diagnosed in 2. 8 (28%) were diagnosed with atopic dermatitis, 6 (21%) with mental retardation, 3 (10%) with acute urticaria, and 2 (7%) with allergic rhinitis. Gastroesophageal reflux disease (GERD) was diagnosed in 7, all requiring LTOT. The frequency of episodes of respiratory infection was maximum in the first 2 years of life, amounting to 16 episodes per 2 years (Me 7; IQR 4 to 10), and the maximum frequency of hospitalizations during this age period was 5 (Me 2; IQR 1 to 2). Children-passive smokers were diagnosed with malnutrition more often (75%, p=0.449) and required LTOT more often (75%, p=0.694), were more often hospitalized (42%, p=0.422). Despite the possible need for LTOT patients with NEHI had COVID-19 in the form of nasopharyngitis in the majority of cases (89%). Only 8 out of 14 patients had symptoms of NEHI after 5 years of age, and only 1 out of 5 after 7 years. Malnutrition (body mass index for the age<-2) in the first year of life was diagnosed in 13 (45%) children. Malnutrition persisted in 9 out of 24 (37%) by the second year of life, in 5 out of 19 (26%) by the third year, and in 2 out of 14 (14%) by the fourth year of life. Not a single child died. Conclusion: the course of NEHI is characterized by the absence of lethal outcomes, frequent respiratory infections that led to hospitalizations in the first 2 years of life, mild course of COVID-19, regression of clinical symptoms and malnutrition as the child grows, comorbidity with atopic diseases and GERD. The priority should be given to the prevention of passive smoking in children with NEHI.

13 October 2023 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
MKM.A. Karpenko
M.A. Karpenko
ASA.A. Stolov
A.A. Stolov
MMM.T. Maigadzhieva
M.T. Maigadzhieva
DKD.A. Kravchuk
D.A. Kravchuk
IKI.V. Krsheminskaya
I.V. Krsheminskaya
DCDubai KindCare Medical Center
Dubai KindCare Medical Center